| |
| |
|
| Insider
Information: |
Alnylam Pharmaceuticals, Inc. |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
4,896,716 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$9,891,366 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
4,896,716 |
|
|
| Total
Value |
$9,891,366 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
2016-02-23 |
4,896,716 |
2012-10-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
52 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2012-10-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,150,500 |
6,150,500 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-07-02 |
4 |
AS |
$8.07 |
$25,011 |
D/D |
(3,100) |
6,139,800 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-07-03 |
4 |
AS |
$8.07 |
$9,678 |
D/D |
(1,200) |
6,138,600 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-07-09 |
4 |
AS |
$7.08 |
$12,748 |
D/D |
(1,800) |
6,136,800 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-07-10 |
4 |
AS |
$6.69 |
$30,109 |
D/D |
(4,500) |
6,132,300 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-07-11 |
4 |
AS |
$6.48 |
$11,339 |
D/D |
(1,750) |
6,130,550 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-07-16 |
4 |
AS |
$6.59 |
$23,058 |
D/D |
(3,500) |
6,127,050 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-07-17 |
4 |
AS |
$6.58 |
$32,906 |
D/D |
(5,000) |
6,122,050 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-07-18 |
4 |
AS |
$6.80 |
$34,001 |
D/D |
(5,000) |
6,117,050 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-07-23 |
4 |
AS |
$6.88 |
$11,702 |
D/D |
(1,700) |
6,115,350 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-07-24 |
4 |
AS |
$6.81 |
$12,598 |
D/D |
(1,850) |
6,113,500 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-07-25 |
4 |
AS |
$6.55 |
$11,137 |
D/D |
(1,700) |
6,111,800 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-07-30 |
4 |
AS |
$6.60 |
$6,602 |
D/D |
(1,000) |
6,110,800 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-07-31 |
4 |
AS |
$6.42 |
$11,235 |
D/D |
(1,750) |
6,109,050 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-08-01 |
4 |
AS |
$6.21 |
$16,153 |
D/D |
(2,600) |
6,106,450 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-08-06 |
4 |
AS |
$7.08 |
$22,300 |
D/D |
(3,150) |
6,103,300 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-08-07 |
4 |
AS |
$6.66 |
$17,322 |
D/D |
(2,600) |
6,100,700 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-08-08 |
4 |
AS |
$6.80 |
$12,583 |
D/D |
(1,850) |
6,098,850 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-08-13 |
4 |
AS |
$7.02 |
$15,788 |
D/D |
(2,250) |
6,096,600 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-08-14 |
4 |
AS |
$7.04 |
$12,324 |
D/D |
(1,750) |
6,094,850 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-08-15 |
4 |
AS |
$6.98 |
$10,115 |
D/D |
(1,450) |
6,093,400 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-08-20 |
4 |
AS |
$7.14 |
$21,424 |
D/D |
(3,000) |
6,090,400 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-08-21 |
4 |
AS |
$6.89 |
$17,222 |
D/D |
(2,500) |
6,087,900 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-08-22 |
4 |
AS |
$6.75 |
$35,443 |
D/D |
(5,250) |
6,082,650 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2014-08-27 |
4 |
AS |
$7.21 |
$10,821 |
D/D |
(1,500) |
6,081,150 |
0 |
- |
|
52 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
